Novartis Ag

Sandoz Gmbh

Peter Gull

Rudolf Markstein

Max Peter Seiler

Esteban Pombo Villar

Mahavir Prashad

Andrew James Culshaw

Yugang Liu

Hong-Yong Kim

Kaspar Zimmermann

Allan Hallett

Robert Swoboda

The invention provides compounds of formula (I) wherein R, R, R, R, and Rare as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals. 

Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain

The present invention relates to novel benzo [g] quinoline derivatives, their preparation, their use as pharmaceuticals for use in the treatment of glaucoma and myopia.

Quinoline derivatives

The invention provides a compound of formula Iwherein A, B, X, Y and Rare as defined in the description, and a process for preparing them. The compounds of formula I are useful as pharmaceuticals.

Benzo [g] quinoline derivatives for treating glaucoma and myopia

Benzo[g]quinoline derivatives

6-hydroxy or 6-alkoxy-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoxalines bearing in position 4 an optionally substituted phenyl group may be used in the treatment of schizophrenia, drug abuse or self-injurious behavior.

Benzoquinoxalines, pharmaceutical compositions containing them and their

The invention relates to the compound of formula I ##STR1## in free base form or in acid addition salt form its preparation and use as a medicament for glaucoma, depression, Morbus Parkinsonism or cocaine abuse.

Octahydrobenzo[g]quinoline

A compound of formula I ##STR1## wherein R.sub.1 is n-propyl,

Growing community of inventors

Pfeffingen, Switzerland

Peter Gull